Skip to content Tirzepatide is a novel medication that functions as both a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. This dual-action mechanism makes Tirzepatide unique, combining the effects of two incretin hormones released after food intake. By activating both GIP and GLP-1 receptors, Tirzepatide helps regulate insulin production and glucose levels, providing a comprehensive approach to managing blood sugar and weight.
The dual hormone action of Tirzepatide results in several beneficial effects. Firstly, it alerts the pancreas to stop releasing insulin post-meal, preventing excessive insulin production that can lead to hypoglycemia. Secondly, it signals the liver to reduce glucose production, helping maintain stable blood sugar levels. These combined effects contribute to better glycemic control and have been associated with weight loss, as the medication also influences appetite regulation and promotes a feeling of fullness.
Tirzepatide is the active ingredient in branded medications such as Mounjaro and Zepbound. These medications are administered via injections, typically once a week, and have been shown to reduce body weight significantly in clinical trials. Patients considering Tirzepatide for weight loss should consult healthcare providers to determine the appropriate treatment plan. Schedule a visit with our team today to get started on our weight loss program and explore the benefits of Tirzepatide in achieving your weight management goals.
© daneshfar aesthetics – 2024. All rights reserved.
Site Developed and Maintained By :
